Inmed Pharmaceuticals Inc. buy Bankster
Start price
21.01.25
/
50%
€6.45
Target price
21.01.26
-
Performance (%)
-54.42%
End price
31.01.25
€2.94
Summary
This prediction ended on 31.01.25 with a price of €2.94. The BUY prediction by Bankster for Inmed Pharmaceuticals Inc. performed very badly with a performance of -54.42%. Bankster has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Inmed Pharmaceuticals Inc. | - | - |
| iShares Core DAX® | 0.869% | 3.389% |
| iShares Nasdaq 100 | -0.852% | -2.157% |
| iShares Nikkei 225® | 0.436% | 1.060% |
| iShares S&P 500 | -0.122% | -0.270% |
According to Bankster what are the pros and cons of Inmed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Bankster for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Buy Inmed Pharmaceuticals Inc.